Across TCGA pan-cancer cohorts, NDUFA5P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NDUFA5P2’s most consistent transcriptional readouts.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where NDUFA5P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NDUFA5P2 is over-expressed in tumor.
BLCA and THCA are the cancer types where NDUFA5P2 tumor–normal differential expression is most reproducible.